New research reveals stem cell therapy significantly lowers heart failure risk in heart attack survivors. Patients receiving ...
Patients with weak heart function who receive stem cell therapy shortly after a heart attack are less likely to suffer heart ...
News Medical on MSN
Stem cell therapy linked to lower risk of heart failure after a heart attack
Patients with weak heart function who receive stem cell therapy shortly after a heart attack are at lower risk of developing heart failure and related hospital stays compared with standard care, finds ...
New whitepaper demonstrates how CA enables primary care teams in resource-constrained settings to prevent, detect, and manage chronic disease.
Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.
VNS Health’s Center for Home Care Policy & Research has helped the company develop an advanced and ever-evolving care ...
The intervention being tested is the CardiAMP cell therapy system, which involves the use of autologous bone marrow mononuclear cells (ABM MNC). These cells are harvested from the patient’s bone ...
Sharecare, the health tech company that helps to improve care quality, drive better outcomes, and lower costs across the healthcare ecosystem, today announced it has again received a three-year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback